BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 21412920)

  • 1. Combination inhaled steroid and long-acting beta(2)-agonist in addition to tiotropium versus tiotropium or combination alone for chronic obstructive pulmonary disease.
    Karner C; Cates CJ
    Cochrane Database Syst Rev; 2011 Mar; (3):CD008532. PubMed ID: 21412920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination inhaled steroid and long-acting beta₂-agonist in addition to tiotropium versus tiotropium or combination alone for chronic obstructive pulmonary disease.
    Rojas-Reyes MX; García Morales OM; Dennis RJ; Karner C
    Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD008532. PubMed ID: 27271056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination inhaled steroid and long-acting beta2-agonist versus tiotropium for chronic obstructive pulmonary disease.
    Welsh EJ; Cates CJ; Poole P
    Cochrane Database Syst Rev; 2013 May; (5):CD007891. PubMed ID: 23728670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-acting beta(2)-agonist in addition to tiotropium versus either tiotropium or long-acting beta(2)-agonist alone for chronic obstructive pulmonary disease.
    Karner C; Cates CJ
    Cochrane Database Syst Rev; 2012 Apr; 4(4):CD008989. PubMed ID: 22513969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-acting beta2-agonist in addition to tiotropium versus either tiotropium or long-acting beta2-agonist alone for chronic obstructive pulmonary disease.
    Farne HA; Cates CJ
    Cochrane Database Syst Rev; 2015 Oct; (10):CD008989. PubMed ID: 26490945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of adding inhaled corticosteroids to tiotropium and long-acting beta(2)-agonists for chronic obstructive pulmonary disease.
    Karner C; Cates CJ
    Cochrane Database Syst Rev; 2011 Sep; 2011(9):CD009039. PubMed ID: 21901729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.
    Spencer S; Evans DJ; Karner C; Cates CJ
    Cochrane Database Syst Rev; 2011 Oct; (10):CD007033. PubMed ID: 21975759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination inhaled steroid and long-acting beta2-agonist versus tiotropium for chronic obstructive pulmonary disease.
    Welsh EJ; Cates CJ; Poole P
    Cochrane Database Syst Rev; 2010 May; (5):CD007891. PubMed ID: 20464758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.
    Spencer S; Karner C; Cates CJ; Evans DJ
    Cochrane Database Syst Rev; 2011 Dec; 2011(12):CD007033. PubMed ID: 22161409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease.
    Chong J; Karner C; Poole P
    Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD009157. PubMed ID: 22972134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.
    Nannini LJ; Lasserson TJ; Poole P
    Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD006829. PubMed ID: 22972099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus inhaled corticosteroids alone for chronic obstructive pulmonary disease.
    Nannini LJ; Poole P; Milan SJ; Kesterton A
    Cochrane Database Syst Rev; 2013 Aug; 2013(8):CD006826. PubMed ID: 23990350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-acting muscarinic antagonists (LAMA) added to combination long-acting beta2-agonists and inhaled corticosteroids (LABA/ICS) versus LABA/ICS for adults with asthma.
    Kew KM; Dahri K
    Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD011721. PubMed ID: 26798035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Once-daily long-acting beta₂-agonists/inhaled corticosteroids combined inhalers versus inhaled long-acting muscarinic antagonists for people with chronic obstructive pulmonary disease.
    Sliwka A; Jankowski M; Gross-Sondej I; Storman M; Nowobilski R; Bala MM
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012355. PubMed ID: 30141826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aclidinium bromide for stable chronic obstructive pulmonary disease.
    Ni H; Soe Z; Moe S
    Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD010509. PubMed ID: 25234126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined aclidinium bromide and long-acting beta2-agonist for chronic obstructive pulmonary disease (COPD).
    Ni H; Moe S; Soe Z; Myint KT; Viswanathan KN
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD011594. PubMed ID: 30536566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tiotropium versus placebo for chronic obstructive pulmonary disease.
    Karner C; Chong J; Poole P
    Cochrane Database Syst Rev; 2012 Jul; (7):CD009285. PubMed ID: 22786525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined corticosteroid and long-acting beta-agonist in one inhaler versus long-acting beta-agonists for chronic obstructive pulmonary disease.
    Nannini LJ; Cates CJ; Lasserson TJ; Poole P
    Cochrane Database Syst Rev; 2007 Oct; (4):CD006829. PubMed ID: 17943918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tiotropium versus placebo for chronic obstructive pulmonary disease.
    Karner C; Chong J; Poole P
    Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD009285. PubMed ID: 25046211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease.
    Cheyne L; Irvin-Sellers MJ; White J
    Cochrane Database Syst Rev; 2013 Sep; (9):CD009552. PubMed ID: 24043433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.